172 related articles for article (PubMed ID: 11828420)
1. Preparation and antimalarial activities of "trioxaquines", new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline.
Dechy-Cabaret O; Benoit-Vical F; Robert A; Meunier B
Chembiochem; 2000 Nov; 1(4):281-3. PubMed ID: 11828420
[No Abstract] [Full Text] [Related]
2. A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs.
O'Neill PM; Ward SA; Berry NG; Jeyadevan JP; Biagini GA; Asadollaly E; Park BK; Bray PG
Curr Top Med Chem; 2006; 6(5):479-507. PubMed ID: 16719804
[TBL] [Abstract][Full Text] [Related]
3. 4-Aminoquinoline derivatives: Synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites.
Singh S; Agarwal D; Sharma K; Sharma M; Nielsen MA; Alifrangis M; Singh AK; Gupta RD; Awasthi SK
Eur J Med Chem; 2016 Oct; 122():394-407. PubMed ID: 27394399
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of ring-substituted 4-aminoquinolines and evaluation of their antimalarial activities.
Madrid PB; Sherrill J; Liou AP; Weisman JL; Derisi JL; Guy RK
Bioorg Med Chem Lett; 2005 Feb; 15(4):1015-8. PubMed ID: 15686903
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimalarial activity of trioxaquine derivatives.
Dechy-Cabaret O; Benoit-Vical F; Loup C; Robert A; Gornitzka H; Bonhoure A; Vial H; Magnaval JF; Séguéla JP; Meunier B
Chemistry; 2004 Apr; 10(7):1625-36. PubMed ID: 15054749
[TBL] [Abstract][Full Text] [Related]
6. Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain.
Sinha M; Dola VR; Agarwal P; Srivastava K; Haq W; Puri SK; Katti SB
Bioorg Med Chem; 2014 Jul; 22(14):3573-86. PubMed ID: 24906512
[TBL] [Abstract][Full Text] [Related]
7. Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes.
Benoit-Vical F; Lelièvre J; Berry A; Deymier C; Dechy-Cabaret O; Cazelles J; Loup C; Robert A; Magnaval JF; Meunier B
Antimicrob Agents Chemother; 2007 Apr; 51(4):1463-72. PubMed ID: 17242150
[TBL] [Abstract][Full Text] [Related]
8. Trioxaferroquines as new hybrid antimalarial drugs.
Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
[TBL] [Abstract][Full Text] [Related]
9. Antimalarial activity of novel 5-aryl-8-aminoquinoline derivatives.
Shiraki H; Kozar MP; Melendez V; Hudson TH; Ohrt C; Magill AJ; Lin AJ
J Med Chem; 2011 Jan; 54(1):131-42. PubMed ID: 21141892
[TBL] [Abstract][Full Text] [Related]
10. Overcoming drug resistance to heme-targeted antimalarials by systematic side chain variation of 7-chloro-4-aminoquinolines.
Yearick K; Ekoue-Kovi K; Iwaniuk DP; Natarajan JK; Alumasa J; de Dios AC; Roepe PD; Wolf C
J Med Chem; 2008 Apr; 51(7):1995-8. PubMed ID: 18345611
[TBL] [Abstract][Full Text] [Related]
11. Quinoline-pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies.
Singh K; Kaur H; Smith P; de Kock C; Chibale K; Balzarini J
J Med Chem; 2014 Jan; 57(2):435-48. PubMed ID: 24354322
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 4-aminoquinoline-1,2,3-triazole and 4-aminoquinoline-1,2,3-triazole-1,3,5-triazine hybrids as potential antimalarial agents.
Manohar S; Khan SI; Rawat DS
Chem Biol Drug Des; 2011 Jul; 78(1):124-36. PubMed ID: 21457474
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents.
Pandey S; Agarwal P; Srivastava K; Rajakumar S; Puri SK; Verma P; Saxena JK; Sharma A; Lal J; Chauhan PM
Eur J Med Chem; 2013 Aug; 66():69-81. PubMed ID: 23792317
[TBL] [Abstract][Full Text] [Related]
14. Novel conjugated quinoline-indoles compromise Plasmodium falciparum mitochondrial function and show promising antimalarial activity.
Teguh SC; Klonis N; Duffy S; Lucantoni L; Avery VM; Hutton CA; Baell JB; Tilley L
J Med Chem; 2013 Aug; 56(15):6200-15. PubMed ID: 23837878
[TBL] [Abstract][Full Text] [Related]
15. Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro.
De D; Krogstad FM; Cogswell FB; Krogstad DJ
Am J Trop Med Hyg; 1996 Dec; 55(6):579-83. PubMed ID: 9025680
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives.
Solomon VR; Haq W; Srivastava K; Puri SK; Katti SB
J Med Chem; 2007 Jan; 50(2):394-8. PubMed ID: 17228883
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of DU-1102, a new trioxaquine derivative, against Plasmodium falciparum isolates.
Basco LK; Dechy-Cabaret O; Ndounga M; Meche FS; Robert A; Meunier B
Antimicrob Agents Chemother; 2001 Jun; 45(6):1886-8. PubMed ID: 11353644
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimalarial activity of novel side chain modified antimalarial agents derived from 4-aminoquinoline.
Solomon VR; Haq W; Smilkstein M; Srivastava K; Rajakumar S; Puri SK; Katti SB
Med Chem; 2008 Sep; 4(5):446-56. PubMed ID: 18782041
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of phenylequine for antimalarial activity in vitro and in vivo.
Blackie MA; Yardley V; Chibale K
Bioorg Med Chem Lett; 2010 Feb; 20(3):1078-80. PubMed ID: 20034790
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of a 3-(2,2,2-trifluoroethyl)-γ-hydroxy-γ-lactam motif in the side chain of 4-aminoquinolines. Syntheses and antimalarial activities.
Cornut D; Lemoine H; Kanishchev O; Okada E; Albrieux F; Beavogui AH; Bienvenu AL; Picot S; Bouillon JP; Médebielle M
J Med Chem; 2013 Jan; 56(1):73-83. PubMed ID: 23102258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
